Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Translational Stroke Research|January 26, 2022
Test-retest reliability of arterial spin labelling for cerebral blood flow in older adults with small vessel diseaseLauren R Binnie, Mathilde M H Pauls, Philip Benjamin, et al.
Cerebral Circulation - Cognition and Behavior|October 9, 2023
Testing the cognitive effects of tadalafil. Neuropsychological secondary outcomes from the PASTIS trialMathilde Mh Pauls, Jessica Fish, Lauren R Binnie, et al.
The Canadian Journal of Cardiology|June 26, 2016
Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer TherapySean A Virani, Susan Dent, Christine Brezden-Masley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 8, 2022
The PASTIS trial: Testing tadalafil for possible use in vascular cognitive impairmentMathilde M H Pauls, Lauren R Binnie, Philip Benjamin, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2008
BACE-1 inhibitors part 3: identification of hydroxy ethylamines (HEAs) with nanomolar potency in cellsPaul Beswick, Nicolas Charrier, Brian Clarke, et al.
The Canadian Journal of Cardiology|December 11, 2020
Cardiovascular Care Delivery During the Second Wave of COVID-19 in CanadaIdan Roifman, Rakesh C Arora, David Bewick, et al.
The Lancet Regional Health. Europe|December 11, 2023
Prevention of infections and fever to improve outcome in older patients with acute stroke (PRECIOUS): a randomised, open, phase III, multifactorial, clinical trial with blinded outcome assessmentJeroen C de Jonge, Wouter M Sluis, Hendrik Reinink, et al.
The Canadian Journal of Cardiology|June 20, 2020
Cardiac Rehabilitation During the COVID-19 Era: Guidance on Implementing Virtual CareNathaniel Moulson, David Bewick, Tracy Selway, et al.
The Canadian Journal of Cardiology|October 19, 2025
Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%)Sean Virani, Shelley Zieroth, Natasha Aleksova, et al.
The Canadian Journal of Cardiology|April 8, 2021
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection FractionMichael McDonald, Sean Virani, Michael Chan, et al.
Pageof 7